Annual ReportHealthcare

CSL Limited

CSL.AX · Period ending 2026-06-30 · Filed 2026-06-30 · Updated

Financial statements are in USD, the currency CSL Limited reports in; the share price is quoted in AUD.

In short

CSL Limited (CSL.AX) has revenue up 1.7% to $15.7B year on year. Its net margin is -16.4% and gross margin 50.8%. Fisclear flags 1 high-severity risk, led by: Net loss of $2.6B — the company spent more than it earned. Investors should monitor the path to profitability. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

A$183.84

Market Cap

A$88.2B

P/B

4.1x

Price ÷ book value

P/S (TTM)

5.6x

Price ÷ revenue per share

Beta

0.08

Low volatility vs market

PEG Ratio

1.8x

P/E ÷ earnings growth rate

52-Week Range

A$90.00A$183.84 nowA$222.47

4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)

Efficiency
41/100
Value
50/100
Cashflow
40/100
Regime
55/100

⚠ Negative ROE — equity capital being destroyed.

Based on filing period ending Jun 2026

International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.

CSL.AX vs

🇦🇺 Australia Macro Indicators

Full dashboard →

10-Year Yield

5.01%↑

AUD/USD

0.70→

The 10-year government bond yield is 5.01%; AUD/USD is at 0.6953.

SWOT Analysis — CSL.AX

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

No standout strengths identified from the filing.

◈

Weaknesses

  • EPS (Diluted): USD -5.35 (-186.7% YoY) — Negative EPS — the company recorded a loss on a per-share basis.

  • Net Income: -$2.6B (-185.9% YoY) — The company posted a net loss — total expenses exceeded total revenue.

  • Total Assets: $33.6B (-14.6% YoY) — Total assets shrank 15% — the balance sheet contracted.

◎

Opportunities

  • Revenue: $15.7B (+1.7% YoY) — Revenue grew 2% — the company sold more goods or services than the prior year.

  • Gross Profit: $8.0B (+0.3% YoY) — Gross profit rose 0% — the spread between revenue and direct costs improved.

⚠

Threats

  • Net loss of $2.6B — the company spent more than it earned. Investors should monitor the path to profitability.

Financial Charts

Revenue vs Net Income

Gross Profit vs Operating Income

Margin Trend

Year-over-Year Changes

EPS (Diluted)

USD -5.35

was USD 6.17

−186.7%

Negative EPS — the company recorded a loss on a per-share basis.

Net Income

-$2.6B

was $3.0B

−185.9%

The company posted a net loss — total expenses exceeded total revenue.

Total Assets

$33.6B

was $39.4B

−14.6%

Total assets shrank 15% — the balance sheet contracted.

Revenue

$15.7B

was $15.4B

+1.7%

Revenue grew 2% — the company sold more goods or services than the prior year.

Gross Profit

$8.0B

was $8.0B

+0.3%

Gross profit rose 0% — the spread between revenue and direct costs improved.

Risk Flags

1 high · 0 medium · 0 low
  • ⚠ High

    Net loss of $2.6B — the company spent more than it earned. Investors should monitor the path to profitability.

Price HistoryAUD

Technical Signals

Daily closes · 1-year data

Latest News

via Finnhub

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Research CSL Limited

Data sourced from ASX, FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.